Search - tctmd.com

Displaying 41 - 60 of 172

Sort: Relevancy | Date

News Daily News

Better Outcomes, Including Mortality, With IVUS-Guided PCI: Medicare Analysis

Michael O'Riordan

August 18, 2020

News Daily News

Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement

Yael L. Maxwell

August 06, 2020

News Daily News

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

Caitlin E. Cox

May 08, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

News CV Team Pro

The Emory Healthcare Cath Lab Teams

L.A. McKeown

December 18, 2019

News Industry News

Penumbra Announces First Patient Enrolled In Study Of Mechanical Power Aspiration For Thrombus Removal In Coronary Vessels

October 10, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

Presentation TCT 2019

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

Presenter: David Erlinge

September 27, 2019

Presentation TCT 2019

TCT 69: A Prospective, Multi-center, Randomized Study to Evaluate the Optimal Strategy for Side Branch Treatment in Patients with Left Main Coronary Bifurcation Lesion (SMART-STRATEGY II)

Presenter: Kim Jihoon

September 25, 2019

News Daily News

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Caitlin E. Cox

May 14, 2019

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Daily News

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Michael O'Riordan

October 17, 2018

News Conference News TCT 2018

The End of BMS? LEADERS FREE II Shows Superiority of Polymer-Free, Drug-Coated Stent

Yael L. Maxwell

September 22, 2018

News Conference News ESC 2018

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

Shelley Wood

August 28, 2018

News Conference News EuroPCR 2018

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

Caitlin E. Cox

May 31, 2018

News Daily News

Certain CAD Subgroups Without Severe HF Face Heightened Risk of Sudden Cardiac Death

Todd Neale

May 02, 2018

News Conference News SCAI 2018

PERSPECTIVE: Contemporary Technique and Practice Confer Clinical Success and QoL Benefit for CTO PCI

L.A. McKeown

April 26, 2018

News Daily News

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

Todd Neale

February 21, 2018

News Daily News

Complete Revascularization for STEMI the Way to Go Even Though Evidence Isn’t Definitive: Meta-analysis

Yael L. Maxwell

February 15, 2018

Advertisement

Better Outcomes, Including Mortality, With IVUS-Guided PCI: Medicare Analysis

Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

The Emory Healthcare Cath Lab Teams

Penumbra Announces First Patient Enrolled In Study Of Mechanical Power Aspiration For Thrombus Removal In Coronary Vessels

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

TCT 69: A Prospective, Multi-center, Randomized Study to Evaluate the Optimal Strategy for Side Branch Treatment in Patients with Left Main Coronary Bifurcation Lesion (SMART-STRATEGY II)

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Top News in Coronary Artery Disease: 2018

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

The End of BMS? LEADERS FREE II Shows Superiority of Polymer-Free, Drug-Coated Stent

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

Certain CAD Subgroups Without Severe HF Face Heightened Risk of Sudden Cardiac Death

PERSPECTIVE: Contemporary Technique and Practice Confer Clinical Success and QoL Benefit for CTO PCI

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

Complete Revascularization for STEMI the Way to Go Even Though Evidence Isn’t Definitive: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content